What is German Bionic?
Founded in 2016 and headquartered in Augsburg, Germany, German Bionic specializes in creating advanced exoskeletons that augment human capabilities in industrial production environments. Their flagship product, the Cray X power suit, intelligently combines human intent with machine power, offering substantial support for lifting movements—up to 66 lb (30 kg) per lift—and providing up to ten tons of relief per shift. This technology is crucial in mitigating the risk of work-related injuries and illnesses. With additional offices in Berlin, Tokyo, and Boston, German Bionic is positioned as a global leader in wearable robotics for industrial applications.
How much funding has German Bionic raised?
German Bionic has raised a total of $35M across 2 funding rounds:
Series A
$20M
Debt
$15M
Series A (2020): $20M, investors not publicly disclosed
Debt (2022): $15M led by European Investment Bank
Key Investors in German Bionic
European Investment Bank
Established in 1958 and headquartered in Luxembourg, European Investment Bank (EIB) is the European Union's nonprofit long-term lending and finance institution.
What's next for German Bionic?
The recent major strategic investment in German Bionic signals a strong confidence in the company's potential to scale its operations and further innovate its exoskeleton technology. This capital infusion is likely to fuel research and development, expand manufacturing capabilities, and broaden market reach, particularly in key industrial regions. As the company continues to grow, its focus will remain on enhancing worker well-being and operational efficiency through advanced robotic augmentation, solidifying its position in the burgeoning industrial exoskeleton market.
See full German Bionic company page
